Literature DB >> 2707305

Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.

G J Kilpatrick1, B J Jones, M B Tyers.   

Abstract

The radiolabelled derivative of the potent and selective 5-HT3 receptor antagonist, GR65630, has been shown to label 5-HT3 receptors in homogenates of rat entorhinal cortex. We now report on the specific binding of this radioligand in homogenates of 16 discrete brain areas from several species and nine areas of human brain. We have further characterised specific binding to homogenates of rat area postrema and vagus nerve. In all species examined (rat, mouse, rabbit and ferret) the highest level of specific [3H]GR65630 (0.2 nM) binding was found in homogenates of the area postrema (26-83 fmol/mg protein). Binding in forebrain areas varied with species, Rat and mouse brain had relatively high levels of binding in cortical areas. The ferret and rat had relatively high levels in forebrain dopamine-containing areas. Of the areas of human brain examined the amygdala showed the highest level of specific [3H]GR65630 (0.2 nM) binding (3.0 fmol/mg protein). Specific [3H]GR65630 (0.05-2 nM) binding to homogenates of rat vagus nerve and area postrema was saturable (Bmax: vagus nerve 89.1 fmol/mg protein, area postrema 44.4 fmol/mg protein) and of high affinity (Kd: vagus nerve 0.50 nM, area postrema 0.24 nM). Selective 5-HT3 receptor agonists and antagonists potently inhibited [3H]GR65630 (0.2 nM) binding to homogenates of rat area postrema and vagus nerve. There was a close correlation between drug affinities in each area.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707305     DOI: 10.1016/0014-2999(89)90700-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  50 in total

1.  Intragastric capsaicin stimulates motility of upper gut and proximal colon via distinct pathways in conscious dogs.

Authors:  C Shibata; I Sasaki; H Naito; T Ueno; S Matsuno
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

Review 2.  Neuropharmacology of emesis in relation to clinical response.

Authors:  B Costall; R J Naylor
Journal:  Br J Cancer Suppl       Date:  1992-12

3.  Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract.

Authors:  S Champaneria; B Costall; R J Naylor; D W Robertson
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

4.  Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.

Authors:  G A Higgins; B J Jones; N R Oakley; M B Tyers
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.

Authors:  A Butler; C J Elswood; J Burridge; S J Ireland; K T Bunce; G J Kilpatrick; M B Tyers
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

6.  Human responses to inhaled capsaicin are not inhibited by granisetron.

Authors:  N B Choudry; J R McEwan; E A Lavender; A J Williams; R W Fuller
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

7.  Characteristics for enhanced response of serotonin-evoked ion dynamics in differentiated NG108-15 cells.

Authors:  Takashi Imanishi; Kayoko Matsushima; Akinori Kawaguchi; Hajime Asano; Yoshinori Funakami; Tetsuyuki Wada; Takashi Masuko; Shigeru Yoshida; Seiji Ichida
Journal:  Neurochem Res       Date:  2008-12-12       Impact factor: 3.996

8.  Control of emesis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide.

Authors:  E H Tan; P T Ang; K S Khoo
Journal:  Support Care Cancer       Date:  1994-05       Impact factor: 3.603

9.  Identification of unique release kinetics of serotonin from guinea-pig and human enterochromaffin cells.

Authors:  Ravinarayan Raghupathi; Michael D Duffield; Leah Zelkas; Adrian Meedeniya; Simon J H Brookes; Tiong Cheng Sia; David A Wattchow; Nick J Spencer; Damien J Keating
Journal:  J Physiol       Date:  2013-10-07       Impact factor: 5.182

10.  Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatment.

Authors:  Norbert Gyongyosi; Brigitta Balogh; Zita Katai; Eszter Molnar; Rudolf Laufer; Kornelia Tekes; Gyorgy Bagdy
Journal:  J Neural Transm (Vienna)       Date:  2010-01-06       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.